Biomar Microbial Technologies - Product Pipeline Review - 2016

  • ID: 4035463
  • Company Profile
  • 49 pages
  • Global Markets Direct
1 of 4
Biomar Microbial Technologies - Product Pipeline Review - 2016

Summary

‘Biomar Microbial Technologies - Product Pipeline Review - 2016’, provides an overview of the Biomar Microbial Technologies’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Biomar Microbial Technologies, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope:

- The report provides a snapshot of the pipeline therapeutic landscape of Biomar Microbial Technologies
- The report provides overview of Biomar Microbial Technologies including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Biomar Microbial Technologies’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Biomar Microbial Technologies’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to Buy:

- Evaluate Biomar Microbial Technologies’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Biomar Microbial Technologies
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Biomar Microbial Technologies’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Introduction

Biomar Microbial Technologies Snapshot

Biomar Microbial Technologies Overview

Key Facts

Biomar Microbial Technologies - Research and Development Overview

Key Therapeutic Areas

Biomar Microbial Technologies - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Biomar Microbial Technologies - Pipeline Products Glance

Biomar Microbial Technologies - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Biomar Microbial Technologies - Drug Profiles

IB-05202 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-06202 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-07A037 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-07A081 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-07A085 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-08C175 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-08C179 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-09A0133 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-09A149 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-10A111 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-10C179 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

IB-12A157 - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule 1 for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule 2 for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecule 3 for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules 4 for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Aspergillosis and Candidiasis - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Bacterial Infections - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Glioblastoma - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Multi Drug Resistant Staphylococcus Aureus Infections - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Neuropathic Pain - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules for Tuberculosis - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Antagonize G-Protein-Coupled Receptors for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Antagonize VEGF Receptor for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit Kinase for Oncology - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit NIK for Multiple Sclerosis - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Small Molecules to Inhibit tRNA for Bacterial Infections - Drug Profile

Product Description

Mechanism Of Action

R&D Progress

Biomar Microbial Technologies - Pipeline Analysis

Biomar Microbial Technologies - Pipeline Products by Target

Biomar Microbial Technologies - Pipeline Products by Route of Administration

Biomar Microbial Technologies - Pipeline Products by Molecule Type

Biomar Microbial Technologies - Pipeline Products by Mechanism of Action

Biomar Microbial Technologies - Dormant Projects

Biomar Microbial Technologies - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables:

Biomar Microbial Technologies, Key Facts

Biomar Microbial Technologies - Pipeline by Indication, 2016

Biomar Microbial Technologies - Pipeline by Stage of Development, 2016

Biomar Microbial Technologies - Monotherapy Products in Pipeline, 2016

Biomar Microbial Technologies - Preclinical, 2016

Biomar Microbial Technologies - Discovery, 2016

Biomar Microbial Technologies - Pipeline by Target, 2016

Biomar Microbial Technologies - Pipeline by Route of Administration, 2016

Biomar Microbial Technologies - Pipeline by Molecule Type, 2016

Biomar Microbial Technologies - Pipeline Products by Mechanism of Action, 2016

Biomar Microbial Technologies - Dormant Developmental Projects,2016

List of Figures:

Biomar Microbial Technologies - Pipeline by Top 10 Indication, 2016

Biomar Microbial Technologies - Pipeline by Stage of Development, 2016

Biomar Microbial Technologies - Monotherapy Products in Pipeline, 2016

Biomar Microbial Technologies - Pipeline by Target, 2016

Biomar Microbial Technologies - Pipeline by Molecule Type, 2016

Biomar Microbial Technologies - Pipeline Products by Mechanism of Action,
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll